Yujiro Uchida

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19

Yohei Doi, Masaya Hibino, Ryota Hase et al. · Antimicrobial Agents and Chemotherapy · 2020 · 238 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial

Masaharu Shinkai, Kenji Tsushima, Shingo Tanaka et al. · Infectious Diseases and Therapy · 2021 · 78 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup O25 strains, and associated virulence factors

Yujiro Uchida, Yuiko Morokuma, Makiko Kiyosuke et al. · International Journal of Antimicrobial Agents · 2010 · 29 citations

Life Sciences, Infectious Diseases, Microbiology +17

Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia

Yujiro Uchida, Yuiko Morokuma, Makiko Kiyosuke et al. · International Journal of Antimicrobial Agents · 2010 · 28 citations

Life Sciences, Infectious Diseases, Microbiology +14

Successful Treatment of Pituitary Abscess with Oral Administration of Sparfloxacin

Yujiro Uchida, Noriko Tsuchimochi, Miwako Oku et al. · Internal Medicine · 2008 · 22 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +12